+44 79 19 49 39 39 wilsonblaney@gmail.com

Novartis And the Future Of Drug Pricing
Novartis is bucking that convention by agreeing to let insurers Cigna and Aetna pay different prices for its heart-failure drug, Entresto, based on how it performs. This is not the first or only such deal, but they are rare in the U.S. And this one has …
Read more on Bloomberg


Novartis Now “Responsible” For Zofran’s Warning Label, New Lawsuit Claims
To our knowledge, this is the first lawsuit that attempts to hold Novartis accountable for birth defects allegedly caused by the drug. It was filed by a mother from New Orleans, who says her unborn daughter’s exposure to Zofran caused a heart defect …
Read more on Legal Examiner


Share Button